Related Experiment Video
Updated: Feb 9, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Universal Recommendations for the Management of Acute Diarrhea in Nonmalnourished Children
Alfredo Guarino1, Andrea Lo Vecchio1, Jorge Amil Dias2
1Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Naples, Italy.
Insights
New clinical guidelines for acute gastroenteritis (AGE) in children aim to standardize care. Oral rehydration and probiotics are recommended, reducing inappropriate interventions and improving outcomes globally.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Global Health
Background:
- Clinical practice for childhood acute gastroenteritis (AGE) shows significant variability despite consistent recommendations.
- High rates of inappropriate medical interventions persist globally for children with AGE.
Purpose of the Study:
- To develop worldwide clinical recommendations for managing non-severely malnourished children with AGE.
- Standardize the approach to pediatric acute gastroenteritis treatment.
Main Methods:
- A systematic review and comparison of published guidelines were conducted.
- Delphi methodology was used for agreement on draft recommendations.
- External peer-review and validation by 28 global experts ensured consensus.
Main Results:
- A core set of 23 recommendations for AGE management achieved 91% agreement.
- Expert validation resulted in 87% agreement.
- Oral rehydration and probiotics were the only universally recommended treatments; antidiarrheals and antiemetics showed lower consensus.
Conclusions:
- Universal recommendations can enhance practitioner adherence to guidelines for managing childhood AGE.
- Standardized care is expected to reduce inappropriate interventions.
- Implementation may significantly improve clinical outcomes and reduce healthcare costs.
Objective:
Despite a substantial consistency in recommendations for the management of children with acute gastroenteritis (AGE), a high variability in clinical practice and a high rate of inappropriate medical interventions persist in both developing and developed countries.The aim of this study was to develop a set of clinical recommendations for the management of nonseverely malnourished children with AGE to be applied worldwide.
Methods:
The Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition (FISPGHAN) Working Group (WG) selected care protocols on the management of acute diarrhea in infants and children aged between 1 month and 18 years. The WG used a 3-step approach consisting of: systematic review and comparison of published guidelines, agreement on draft recommendations using Delphi methodology, and external peer-review and validation of recommendations.
Results:
A core of recommendations including definition, diagnosis, nutritional management, and active treatment of AGE was developed with an overall agreement of 91% (range 80%-96%). A total of 28 world experts in pediatric gastroenterology and emergency medicine successively validated the set of 23 recommendations with an agreement of 87% (range 83%-95%). Recommendations on the use of antidiarrheal drugs and antiemetics received the lowest level of agreement and need to be tailored at local level. Oral rehydration and probiotics were the only treatments recommended.
Conclusions:
Universal recommendations to assist health care practitioners in managing children with AGE may improve practitioners' compliance with guidelines, reduce inappropriate interventions, and significantly impact clinical outcome and health care-associated costs.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Coronary Syndrome V: Nursing Management
Acute Kidney Injury VI: Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drug Dosing: Infants and Children

